RNTX
RNTX
NASDAQ · Biotechnology

Rein Therapeutics Inc

$0.56
-0.05 (-7.59%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +8,283.9% upside
Low Target $33.28
Average Target $46.95
High Target $64.49
Current Price $0.56
Current
$0.56
Target
$46.95
$33.28 $46.95 avg $64.49
Scenario Analysis
Bear Case
$33.28
5,842.9%
Low target
Base Case
$46.95
+8,283.9%
Avg target
Bull Case
$64.49
+11,416.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.10
-73.3% from high
52-Week Low
$0.54
+3.7% from low
Target vs 52W High
$46.95
+2,135.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%